Dr. Clesson Turner is a staff clinician and director of the NHGRI Reverse Phenotyping Core. In 1995, he received a B.S. from the University of Notre Dame in Notre Dame, Indiana. After completion of his undergraduate studies, he attended medical school at the University of Vermont College of Medicine in Burlington, Vermont, receiving his M.D. in 1999. Following medical school, he completed a residency in pediatrics through the National Capital Consortium in 2002 and a residency in Clinical Genetics and Clinical Molecular Genetics at NHGRI in 2009. Dr. Turner served as the chief of genetics at Walter Reed National Military Medical Center and as the chief of cancer genetics at the Murtha Cancer Center prior to retiring from the U.S. Army in 2019. After, he was an associate professor in pediatrics and the interim director for precision medicine at the Uniformed Services University of the Health Sciences in Bethesda, MD.
In 2021, Dr. Turner joined NHGRI to direct its Reverse Phenotyping Core in the Center for Precision Health Research. He oversees the daily operations of the core and supervises three core personnel. His major focus is the development and implementation of reverse phenotyping protocols to advance the clinical impact of genomic medicine.